SLR Investment Earnings Call Transcripts
Fiscal Year 2026
-
Q1 2026 saw lower net investment income and portfolio contraction due to reduced fee income and slower deal activity, but credit quality remained strong with 100% performing loans and minimal watch list exposure. Strategic initiatives in ABL and life sciences are expected to drive future growth.
Fiscal Year 2025
-
Fourth quarter and full year 2025 results showed stable portfolio growth, strong credit quality, and a strategic focus on asset-based and specialty finance lending. Management expects continued momentum in 2026, with ample liquidity and disciplined capital deployment.
-
Q3 2025 results showed stable earnings and portfolio quality, with net investment income of $0.40 per share and a slight increase in NAV. Specialty finance and ABL dominate the portfolio, supported by strong originations and robust credit metrics. Dividend remains at $0.41 per share.
-
Q2 2025 saw record new originations and portfolio growth, with specialty finance now 83% of assets and strong credit quality maintained. Net investment income was $0.40 per share, NAV per share rose to $18.19, and the company remains well-capitalized to pursue new opportunities.
-
Q1 2025 results showed stable net investment income and strong portfolio credit quality, with a continued shift toward specialty finance and asset-based lending. The company remains well-capitalized, with minimal tariff exposure and a growing pipeline in ABL and equipment finance.
Fiscal Year 2024
-
Q4 2024 saw stable net investment income, a portfolio yield increase to 12.1%, and NAV growth to $18.20 per share. Specialty finance dominated new originations, while ABL and equipment finance segments expanded amid favorable market shifts.
-
Q3 2024 net investment income was $0.45 per share, with stable NAV and strong credit quality. Specialty finance dominated new originations, and a major factoring portfolio acquisition expanded ABL capabilities. Portfolio yields remain robust, with low non-accruals and ample capital for deployment.
-
Net investment income per share hit a five-year high in Q2 2024, with strong portfolio credit quality and a shift toward specialty finance. The portfolio remains defensively positioned, with low non-accruals and robust capital available for deployment.